Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Muscle contribution in lipid nanoparticle mediated mRNA vaccine delivery and efficacy.

Journal of controlled release : official journal of the Controlled Release Society·2026

Same author

Mapping mRNA Localization and Internal Structure in Lipid Nanoparticles through Solid-State Dynamic Nuclear Polarization NMR and Proton Spin-Diffusion Modeling.

Small methods·2026

Same author

Toward clinically relevant in vitro models for dental implant integration: Methodological insights and translational perspectives.

Dental materials : official publication of the Academy of Dental Materials·2026

Same author

Correction: Filali et al. Morphological and Mechanical Characterization of Extracellular Vesicles and Parent Human Synoviocytes under Physiological and Inflammatory Conditions. <i>Int. J. Mol. Sci.</i> 2022, <i>23</i>, 13201.

International journal of molecular sciences·2026

Same author

Enabling methodology for high-throughput media screening in the context of multi-cell type co-cultures.

Journal of biotechnology·2026

Same author

Bioprinting is not cheap.

Trends in biotechnology·2026

Search research articles

Related Experiment Video

Updated: Jun 18, 2025

Custom-designed Laser-based Heating Apparatus for Triggered Release of Cisplatin from Thermosensitive Liposomes with Magnetic Resonance Image Guidance

Custom-designed Laser-based Heating Apparatus for Triggered Release of Cisplatin from Thermosensitive Liposomes with Magnetic Resonance Image Guidance

Published on: December 13, 2015

Tailor-made vincristine-liposomes for tumor targeting.

Ariana Abawi¹, Ana-Maria Trunfio-Sfarghiu², Céline Thomann¹

¹Institute of Molecular and Supramolecular Chemistry and Biochemistry, ICBMS UMR 5246, Univ. Lyon, University Lyon 1, CNRS, 69622, Lyon, France.

|August 2, 2024

Summary

Fluid liposomes carrying vincristine effectively target cancer cells by disrupting their growth. This research offers a promising, cost-effective approach for cancer therapy, focusing on membrane fluidity for selective drug delivery.

More Related Videos

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Published on: November 1, 2017

Viral Nanoparticles for In vivo Tumor Imaging

Viral Nanoparticles for In vivo Tumor Imaging

Published on: November 16, 2012

Related Experiment Videos

Last Updated: Jun 18, 2025

Custom-designed Laser-based Heating Apparatus for Triggered Release of Cisplatin from Thermosensitive Liposomes with Magnetic Resonance Image Guidance

Custom-designed Laser-based Heating Apparatus for Triggered Release of Cisplatin from Thermosensitive Liposomes with Magnetic Resonance Image Guidance

Published on: December 13, 2015

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Published on: November 1, 2017

Viral Nanoparticles for In vivo Tumor Imaging

Viral Nanoparticles for In vivo Tumor Imaging

Published on: November 16, 2012

Area of Science:

Biotechnology
Nanomedicine
Cancer Research

Background:

Liposomes are lipid-based carriers used for drug delivery.
Vincristine is an anti-tumor compound.
Targeting cancer cells selectively remains a challenge in chemotherapy.

Purpose of the Study:

To design liposomes with varying membrane fluidities for targeted vincristine delivery.
To evaluate the efficacy of these liposomes on cancer cell lines.
To investigate the role of membrane fluidity in cancer cell targeting.

Main Methods:

Liposomes with different membrane fluidities were formulated.
Vincristine was loaded into the liposomes.
Liposome efficacy was tested on prostate, colon, and breast cancer cell lines.
Confocal microscopy was used to visualize intracellular drug release.

Main Results:

Liposomes with fluid membranes significantly reduced cancer cell viability.
Intracellular release of vincristine was confirmed via confocal microscopy.
Disrupted mitosis-specific actin filament labeling indicated drug efficacy in metastatic prostate cells.

Conclusions:

Membrane fluidity is critical for developing effective lipid-based drug carriers.
Fluid liposomes offer a promising strategy for targeted cancer therapy.
This approach provides a cost-effective alternative to conventional cancer treatments.